| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Gso4g0904 | ATGTTCAGTATGAGTCAGGAGCTGAAAAAAGCTGCCTCTAAGGGTCATGAGAAAATGGTAACATCACAAGAAGAGCAGGCAAAGATCACTGAGGTTAGAGGGTTGATAGGGCCACTATCAGATAAGGAATCTGTGTACTGTTCTGATGCTTCCATCTCAAGGTATTTAAGGTCGCGAAATTGGAATGTCAAGAAGGCAGCTCAAATGTTGAAACAGAGCCTAAAATGGAGAAAAGAATACAAACCTGAAGAGATTCGCTGGGAAGAGGTTGCTGAGGAAGCACAGACAGGGATGATGTATAAACCAAATTATCATGACAAGTATGGGAGATCAGTGCTTGTAATGAGACCTTGTGTCCAGAAGTCATCGTCAACACAAGGACAAATTAAGTATTTTGTATACAGCATTGAGCATGCCATTTTAAACCTTCCACCACACCAGGAACAGATGGTCTGGCTGGTAGATTTCCAGGGTTTCAAGCTGTCAGATATATCATTCAAGGTGGCACGTGAATCTGCCCATATTCTGCAAGAGTATTATCCAAAGCAGCTGGGTTTAATAATACTATACAATGCACCTATGATCTTCCAACCATTTTTCTCGATGGTAAAGCCCTTTTTAGAGACTGAGACTGTTAATAAAATAAAGTTTGGCTATTCGAACAACCACAACACAAAGAAGATTATGGAGGATTTGTTTGATAAGGATAATCTTGAATCTGCATTTGGTGGGAATGGTGACACAGGAGTTGACATAAATAAATATGCTGAGAGAATGAAAGAGGATGACAATAAGAAGCATTCTTTCTGGACACAGGCCAAGTCCATATCATCAGTTGCACAAAATGCTCCGTCAGATTCAATCAGGTTAGATGCAGTTTCTGATGCTTCTAACACTAAGAAAATAGACTGTTCCCGTGTCCCTAATTGA | 930 | 0.4022 | MFSMSQELKKAASKGHEKMVTSQEEQAKITEVRGLIGPLSDKESVYCSDASISRYLRSRNWNVKKAAQMLKQSLKWRKEYKPEEIRWEEVAEEAQTGMMYKPNYHDKYGRSVLVMRPCVQKSSSTQGQIKYFVYSIEHAILNLPPHQEQMVWLVDFQGFKLSDISFKVARESAHILQEYYPKQLGLIILYNAPMIFQPFFSMVKPFLETETVNKIKFGYSNNHNTKKIMEDLFDKDNLESAFGGNGDTGVDINKYAERMKEDDNKKHSFWTQAKSISSVAQNAPSDSIRLDAVSDASNTKKIDCSRVPN* | 310 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Gso4g0904 | 309 | Pfam | CRAL/TRIO, N-terminal domain | 8 | 71 | IPR011074 | - | |
| Gso4g0904 | 309 | SMART | sec14_4 | 93 | 247 | IPR001251 | - | |
| Gso4g0904 | 309 | MobiDBLite | consensus disorder prediction | 1 | 25 | - | - | |
| Gso4g0904 | 309 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 87 | 250 | IPR001251 | - | |
| Gso4g0904 | 309 | Gene3D | - | 3 | 282 | IPR036865 | - | |
| Gso4g0904 | 309 | Pfam | CRAL/TRIO domain | 96 | 244 | IPR001251 | - | |
| Gso4g0904 | 309 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 21 | 89 | IPR036273 | - | |
| Gso4g0904 | 309 | PRINTS | Cellular retinaldehyde-binding protein signature | 51 | 73 | - | - | |
| Gso4g0904 | 309 | PRINTS | Cellular retinaldehyde-binding protein signature | 167 | 188 | - | - | |
| Gso4g0904 | 309 | PRINTS | Cellular retinaldehyde-binding protein signature | 200 | 219 | - | - | |
| Gso4g0904 | 309 | PANTHER | CRAL-TRIO LIPID BINDING DOMAIN, CRAL/TRIO DOMAIN-CONTAINING PROTEIN-RELATED | 4 | 309 | - | - | |
| Gso4g0904 | 309 | PANTHER | GH16843P | 4 | 309 | - | - | |
| Gso4g0904 | 309 | CDD | SEC14 | 104 | 245 | IPR001251 | - | |
| Gso4g0904 | 309 | MobiDBLite | consensus disorder prediction | 10 | 24 | - | - | |
| Gso4g0904 | 309 | SMART | CRAL_TRIO_N_2 | 48 | 73 | IPR011074 | - | |
| Gso4g0904 | 309 | SUPERFAMILY | CRAL/TRIO domain | 87 | 265 | IPR036865 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Gso4g0904 | Gso-Chr4 | 9903158 | 9907609 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Gso4g0904 | 51 | 215 | Acyl Lipid Metabolism Gene Families | AT5G47730 | 27.895 | 2.08e-09 | 55.8 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Gso4g0904 | - | - | gmx:100777065 | 616.305 |